Iterum Therapeutics plc logo

Iterum Therapeutics plc (ITRM)

Market Open
8 Aug, 17:32
NASDAQ (CM) NASDAQ (CM)
$
0. 71
+0.02
+2.71%
$
31.01M Market Cap
- P/E Ratio
0% Div Yield
609,912 Volume
-2.35 Eps
$ 0.69
Previous Close
Day Range
0.7 0.76
Year Range
0.66 3.02
Want to track ITRM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 5 days
Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript

Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript

Iterum Therapeutics plc (NASDAQ:ITRM ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Corey N. Fishman - President, CEO & Director Judith M.

Seekingalpha | 2 days ago
Iterum Therapeutics plc (ITRM) Q1 2025 Earnings Call Transcript

Iterum Therapeutics plc (ITRM) Q1 2025 Earnings Call Transcript

Iterum Therapeutics plc (NASDAQ:ITRM ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Louise Barrett - SVP, Legal Affairs Corey Fishman - Chief Executive Officer Judy Matthews - Chief Financial Officer Conference Call Participants Matthew Keller - H.C. Wainwright Operator Hello, everyone, and thank you for joining the Iterum Therapeutics plc First Quarter 2025 Earnings and Business Update Call.

Seekingalpha | 2 months ago
Iterum Therapeutics plc (ITRM) Q4 2024 Earnings Call Transcript

Iterum Therapeutics plc (ITRM) Q4 2024 Earnings Call Transcript

Iterum Therapeutics plc (NASDAQ:ITRM ) Q4 2024 Earnings Conference Call February 7, 2025 8:30 AM ET Company Participants Louise Barrett - SVP, Legal Affairs Corey Fishman - CEO Judy Matthews - CFO Conference Call Participants Thomas Yip - H.C. Wainwright Operator Hello, everyone.

Seekingalpha | 6 months ago
Iterum Therapeutics plc (ITRM) Q3 2024 Earnings Call Transcript

Iterum Therapeutics plc (ITRM) Q3 2024 Earnings Call Transcript

Iterum Therapeutics plc (NASDAQ:ITRM ) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Company Participants Louise Barrett - Senior Vice President, Legal Affairs Corey Fishman - Chief Executive Officer Judith Matthews - Chief Financial Officer Conference Call Participants Thomas Yip - HC Wainwright Jason Mccarthy - Maxim Group Operator Hello, everyone, and thank you for holding, and welcome to the Iterum Therapeutics Reports Third Quarter 2024 Financial Results. My name is Ezra [ph], and I will be your coordinator today.

Seekingalpha | 8 months ago
Iterum Therapeutics plc (ITRM) U.S. FDA Approval of ORLYNVAH Call (Transcript)

Iterum Therapeutics plc (ITRM) U.S. FDA Approval of ORLYNVAH Call (Transcript)

Iterum Therapeutics plc (NASDAQ:ITRM ) U.S. FDA Approval of ORLYNVAH October 28, 2024 8:30 AM ET Company Participants Louise Barrett - SVP, Legal Affairs & Secretary Corey Fishman - President, Director & CEO Steven Aronin - SVP & Head, Clinical Development Conference Call Participants Operator Hello, everyone, and welcome to Iterum Therapeutics call to discuss the recent approval of ORLYNVAH the treatment of Uncomplicated UTIs. My name is Lydia, and I'll be your operator today.

Seekingalpha | 9 months ago
ITRM Posts Updates From FDA Advisory Meeting for UTI Drug, Stock Down

ITRM Posts Updates From FDA Advisory Meeting for UTI Drug, Stock Down

Iterum provides updates from the FDA's Antimicrobial Drugs Advisory Committee meeting on its NDA for oral sulopenem to treat adult women with uUTI.

Zacks | 11 months ago
Iterum Therapeutics plc (ITRM) Q2 2024 Earnings Call Transcript

Iterum Therapeutics plc (ITRM) Q2 2024 Earnings Call Transcript

Iterum Therapeutics plc (NASDAQ:ITRM ) Q2 2024 Results Conference Call August 14, 2024 8:30 AM ET Company Participants Louise Barrett - Senior Vice President of Legal Affairs & Secretary Corey Fishman - President, CEO & Director Judith Matthews - Chief Financial Officer Conference Call Participants Jason McCarthy - Maxim Group Operator Good morning, everyone. Welcome to Iterum Therapeutics Second Quarter 2024 Financial Results and Business Update.

Seekingalpha | 11 months ago